MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw
Noam Yarom*, Catherine H. Van Poznak, Joel B. Epstein, Giulia Ottaviani, Yuhei Matsuda, Cesar Migliorati, Sharon Elad
Research output: Contribution to journal › Review article › peer-review
1Scopus
citations
Fingerprint
Dive into the research topics of 'MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw'. Together they form a unique fingerprint.